Home
Conditions
Muscle-Invasive Bladder Carcinoma

Clinical trial condition

Muscle-Invasive Bladder Carcinoma

Explore clinical trials studying Muscle-Invasive Bladder Carcinoma. Study availability and eligibility vary by location and protocol.

31 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Muscle-Invasive Bladder Carcinoma trial results

Not Yet Recruiting

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

NCT07525349

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer

NCT06528483

Conditions: Bladder Cancer, Bladder Neoplasm, Bladder Urothelial Carcinoma, +12 more
Locations: Fondazione Irccs Istituto Nazionale Dei Tumori Di Milano Milan, Italy

View Trial Details

Not Yet Recruiting

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

NCT06325423

Conditions: Muscle-Invasive Bladder Carcinoma
Locations: Not specified

View Trial Details

Completed

Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

NCT04610671

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

NCT05630131

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: North Carolina Cancer Hospital (UNC) Chapel Hill, North Carolina, United States

View Trial Details

Completed

AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

NCT05028660

Conditions: Muscle-Invasive Bladder Carcinoma
Locations: Zealand University Hospital Roskilde, Denmark

AOU Careggi Florence, Italy

IRCCS Ospedale San Raffaele, San Raffaele Hospital Milan, Italy

IRCCS Regina Elena Rome, Italy

View Trial Details

Completed

Addressing Barriers to Palliative Care Use in Bladder Cancer

NCT04598724

Conditions: Bladder Cancer Stage II, Bladder Cancer Stage III, Bladder Cancer Stage IV, +12 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach

NCT05295992

Conditions: Muscle-Invasive Bladder Carcinoma
Locations: Herlev and Gentofte Hospital Herlev, Denmark

View Trial Details

Active, Not Recruiting

Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

NCT05975307

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations: Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

NCT04506554

Conditions: Muscle-Invasive Bladder Carcinoma
Locations: UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Muscle-Invasive Bladder Carcinoma

Muscle-Invasive Bladder Carcinoma trial results

Related conditions